1 “... 508 accessibility standards and government data rights, we recommend a follow-on pilot be conducted...”

2 “... 508 accessibility standards and government data rights, we recommend a follow-on pilot be conducted...”

3

4

5

6 “..., different doses, and dosing strategies. Uncontrolled studies suggest that nontransport of patients following...”

7 “..., different doses, and dosing strategies. Uncontrolled studies suggest that nontransport of patients following...”

8 “... and on the association between intermediate outcomes following antiviral therapy and clinical outcomes. DATA EXTRACTION...”

9 “...We analyzed effects and assessed strength of evidence (SOE) at short term (1 to <6 months following...”

10 “...We analyzed effects and assessed strength of evidence (SOE) at short term (1 to <6 months following...”

11 “..., and management of postoperative pain following discharge; effects of therapies for acute pain on non-pain...”

12 “... improvements in intermediate outcomes following antiviral therapy and clinical outcomes were heterogeneous...”

13 “... was the most commonly reported outcome, followed by back-specific function. When present, observed benefits...”

14 “... improvements in intermediate outcomes following antiviral therapy and clinical outcomes were heterogeneous...”

15 “... over the following year (relative risk, 0.39 [95% CI, 0.14 to 1.08]), while one previous trial reported...”

16 “... was the most commonly reported outcome, followed by back-specific function. When present, observed benefits...”

17 “... over the following year (relative risk, 0.39 [95% CI, 0.14 to 1.08]), while one previous trial reported...”

18

19

20